JAKi Regulatory Decisions - FDA, EMA, Canada
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
Use this resource to keep track of your clinical trials and key information needed when communicating with patients about a drug study.
Comparison of COVID-19 deaths in the first 3 mos vs. over 30 mos since onset. USA leads the way.
This is part 1 of a 2 part slide series on how to make a MSK diagnosis 7 ways;
Identify “Red Flag” conditions (acute monarticular)
Arthritis by the Numbers (Most Common Stuff 1st )
Outcomes, misdiagnosis, diagnosis, Diagnostic criteria and treatmenet options for AOSD
Overview of the definition, demographics, epidemiology, and presenting features of AOSD
These slides are your notes on how to start a podcast. How and why, with a few suggestions thrown in. These are covered in my XMAS podcast on this subject, found here.